Illness	Number of cases
Mental and behavioural disorders due to use of alcohol (F10.2)	257
Schizophrenia - Paranoid schizophrenia (F20.0)	120
Recurrent depressive disorder - Major depressive disorder recurrent severe without psychotic features (F33.2)	101
Borderline personality disorder (F60.31)	84
Mental and behavioural disorders due to use of other stimulants including caffeine (F15.2)	73
Depressive episode - Major depressive disorder single episode moderate (F32.1)	66
Delirium not induced by alcohol and other psychoactive substances (F05.1)	55
Mental and behavioural disorders due to use of alcohol (F10.0)	54
Depressive episode - Major depressive disorder single episode severe without psychotic features (F32.2)	53
Recurrent depressive disorder - Major depressive disorder recurrent moderate (F33.1)	50

Top 10 treatments

Treatment	Number
(9-649.20)	2.726
(9-649.40)	1.715
Standard treatment for mental and psychosomatic disorders and behavioral disorders in adults (9-607)	1.369
(9-649.0)	1.045
(9-649.50)	873
Intensive treatment for mental and psychosomatic disorders and behavioural disorders in adult patients with one characteristic (9-617)	836
(9-649.12)	833
(9-649.10)	722
Intensive treatment for mental and psychosomatic disorders and behavioural disorders in adult patients with two characteristics (9-618)	583
(9-649.41)	537

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2900 , 2960

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
23	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
4	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
4	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	Lehrbeauftragter am Lehrstuhl für Deutsches, Europäisches und Internationales Strafrecht und Strafprozessrecht sowie Wirtschaftsstrafrecht der Universität Passau; Lehrauftrag an der Dresdner University (DIU)
Project-related cooperation with colleges and universities	Zusammenarbeit mit der Charité; Patientenregister Autoimmune Enzephalitis: Zusammenarbeit im Netzwerk GENERATE; Zusammenarbeit in der Studiengruppe Neuromyelitis optica (NEMOS)
Lectureships / teaching posts at universities of applied sciences	in Zusammenarbeit mit dem Klinikum St. Georg Leipzig
Participation in multi-centre phase III/IV studies	Klinik für Neurologie und neurolgische Intensivmedizin
Initiation and management of uni-centric/multi-centric clinical/scientific studies	Klinik für Neurologie und neurologische Intensivmedizin: MS-Studien (Kognition, Neurodegeneration)
Student training (clinical traineeship / internship year)	nur Famulatur